Identification of early disease progression in an ALS rat model

Jason R. Thonhoff, Paivi M. Jordan, Joseph R. Karam, Brandon L. Bassett, Ping Wu

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Transgenic rat models of amyotrophic lateral sclerosis (ALS) have recently been developed. Most assays of ALS-symptoms in these models monitor disease onset accurately, but do not identify individuals that will develop these symptoms before the motor deficits become apparent. Peak bodyweight has recently been shown to indicate affected individuals before motor deficits become apparent. However, it must be determined retrospectively due to weight fluctuation. Here, we report that exploratory activities detected by a photobeam activity system (PAS) and wire mesh ascending test can be used to detect slight motor deficits in the early phase of ALS. Thus, these tests may be used in addition to peak bodyweight to monitor early disease progression and to assay efficacy of new therapeutic interventions.

Original languageEnglish (US)
Pages (from-to)264-268
Number of pages5
JournalNeuroscience Letters
Volume415
Issue number3
DOIs
StatePublished - Mar 30 2007

Fingerprint

Amyotrophic Lateral Sclerosis
Disease Progression
Transgenic Rats
Weights and Measures
Therapeutics

Keywords

  • Amyotrophic lateral sclerosis (ALS)
  • Motor function
  • Superoxide dismutase 1
  • Transgenic rat

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Identification of early disease progression in an ALS rat model. / Thonhoff, Jason R.; Jordan, Paivi M.; Karam, Joseph R.; Bassett, Brandon L.; Wu, Ping.

In: Neuroscience Letters, Vol. 415, No. 3, 30.03.2007, p. 264-268.

Research output: Contribution to journalArticle

Thonhoff, JR, Jordan, PM, Karam, JR, Bassett, BL & Wu, P 2007, 'Identification of early disease progression in an ALS rat model', Neuroscience Letters, vol. 415, no. 3, pp. 264-268. https://doi.org/10.1016/j.neulet.2007.01.028
Thonhoff, Jason R. ; Jordan, Paivi M. ; Karam, Joseph R. ; Bassett, Brandon L. ; Wu, Ping. / Identification of early disease progression in an ALS rat model. In: Neuroscience Letters. 2007 ; Vol. 415, No. 3. pp. 264-268.
@article{b912f55aa63c49a9aa88489953e005e9,
title = "Identification of early disease progression in an ALS rat model",
abstract = "Transgenic rat models of amyotrophic lateral sclerosis (ALS) have recently been developed. Most assays of ALS-symptoms in these models monitor disease onset accurately, but do not identify individuals that will develop these symptoms before the motor deficits become apparent. Peak bodyweight has recently been shown to indicate affected individuals before motor deficits become apparent. However, it must be determined retrospectively due to weight fluctuation. Here, we report that exploratory activities detected by a photobeam activity system (PAS) and wire mesh ascending test can be used to detect slight motor deficits in the early phase of ALS. Thus, these tests may be used in addition to peak bodyweight to monitor early disease progression and to assay efficacy of new therapeutic interventions.",
keywords = "Amyotrophic lateral sclerosis (ALS), Motor function, Superoxide dismutase 1, Transgenic rat",
author = "Thonhoff, {Jason R.} and Jordan, {Paivi M.} and Karam, {Joseph R.} and Bassett, {Brandon L.} and Ping Wu",
year = "2007",
month = "3",
day = "30",
doi = "10.1016/j.neulet.2007.01.028",
language = "English (US)",
volume = "415",
pages = "264--268",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Identification of early disease progression in an ALS rat model

AU - Thonhoff, Jason R.

AU - Jordan, Paivi M.

AU - Karam, Joseph R.

AU - Bassett, Brandon L.

AU - Wu, Ping

PY - 2007/3/30

Y1 - 2007/3/30

N2 - Transgenic rat models of amyotrophic lateral sclerosis (ALS) have recently been developed. Most assays of ALS-symptoms in these models monitor disease onset accurately, but do not identify individuals that will develop these symptoms before the motor deficits become apparent. Peak bodyweight has recently been shown to indicate affected individuals before motor deficits become apparent. However, it must be determined retrospectively due to weight fluctuation. Here, we report that exploratory activities detected by a photobeam activity system (PAS) and wire mesh ascending test can be used to detect slight motor deficits in the early phase of ALS. Thus, these tests may be used in addition to peak bodyweight to monitor early disease progression and to assay efficacy of new therapeutic interventions.

AB - Transgenic rat models of amyotrophic lateral sclerosis (ALS) have recently been developed. Most assays of ALS-symptoms in these models monitor disease onset accurately, but do not identify individuals that will develop these symptoms before the motor deficits become apparent. Peak bodyweight has recently been shown to indicate affected individuals before motor deficits become apparent. However, it must be determined retrospectively due to weight fluctuation. Here, we report that exploratory activities detected by a photobeam activity system (PAS) and wire mesh ascending test can be used to detect slight motor deficits in the early phase of ALS. Thus, these tests may be used in addition to peak bodyweight to monitor early disease progression and to assay efficacy of new therapeutic interventions.

KW - Amyotrophic lateral sclerosis (ALS)

KW - Motor function

KW - Superoxide dismutase 1

KW - Transgenic rat

UR - http://www.scopus.com/inward/record.url?scp=33947177318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947177318&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2007.01.028

DO - 10.1016/j.neulet.2007.01.028

M3 - Article

C2 - 17280785

AN - SCOPUS:33947177318

VL - 415

SP - 264

EP - 268

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

IS - 3

ER -